Certified by Founder Lodge
Eligo Bioscience
France - Paris, Il de France
START UP
1 Disclosed Funding Rounds $30,000,000
0 Participating Investments
-
Founded date
2014
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Eligo Bioscience is a biotechology company that develops a new class of biotherapeutics for microbiome precision-editing.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| December, 06 ,2023 | Series B | $30,000,000 |
Seventure Partners
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Katalist | $1,500,000 | (Dec 19, 2025)
Amphix Bio | $12,500,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
